Second-line pharmacotherapy intensification after metformin monotherapy in type 2 diabetes: a nationwide register study from Finland during 2011-2022.
二型糖尿病中,單一使用 metformin 後的第二線藥物治療強化:2011-2022 年芬蘭的全國登記研究。
BMC Health Serv Res 2024-08-19
Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications.
關於核苷酸結合寡聚化結構域樣受體蛋白 3 (NLRP3) 發炎小體途徑在糖尿病中的角色的綜述:機制洞察與治療啟示。
Inflammopharmacology 2024-08-19
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.
肥胖中 GLP-1 生理學及基於促胰島素的藥物在慢性體重管理中的發展。
Nat Metab 2024-08-19
Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health.
重新平衡腸道:Glucagon-Like Peptide-1 受體激動劑作為肥胖和代謝健康的策略。
Cureus 2024-08-19
Targeting Microglial GLP1R in Epilepsy: A Novel Approach to Modulate Neuroinflammation and Neuronal Apoptosis.
針對癲癇中的微膠質細胞 GLP1R:調節神經炎症和神經元凋亡的新穎方法。
Eur J Pharmacol 2024-08-18